Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
15.61
+0.41 (2.66%)
May 5, 2026, 12:00 PM EDT - Market open
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$476,663
Profits / Employee
-$117,163
Market Cap
18.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Neurocrine Biosciences | 2,000 |
VTRS News
- 5 hours ago - Viatris Announces Quarterly Dividend - PRNewsWire
- 19 hours ago - Viatris Announces Chief Financial Officer Transition - PRNewsWire
- 4 days ago - Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting - PRNewsWire
- 22 days ago - Viatris to Report First Quarter 2026 Financial Results on May 7, 2026 - PRNewsWire
- 25 days ago - Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting - PRNewsWire
- 5 weeks ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 6 weeks ago - Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) - PRNewsWire
- 6 weeks ago - Viatris Transcript: Investor update - Transcripts